16
Participants
Start Date
September 30, 2014
Primary Completion Date
November 30, 2014
Study Completion Date
December 31, 2014
BI 1060469
tablet, oral administration with 240 mL of water after an overnight fast of at least 10 h
BI 1060469
tablet, oral administration with 240 mL water 30 minutes after subject is served a standardised high-caloric high-fat administration
Other: standard breakfast
tablet, oral administration with 240 mL water 30 minutes after subject is served a standardised high-caloric high-fat administration
1333.44.1 Boehringer Ingelheim Investigational Site, Ingelheim
Lead Sponsor
Boehringer Ingelheim
INDUSTRY